US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 25.060
  • -0.070-0.28%
Close Oct 31 16:00 ET
  • 25.150
  • +0.090+0.36%
Post 19:23 ET
3.88BMarket Cap36.85P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 98.702M--
--2024/Q3-- / 81.705M--
Aug 6, 20242024/Q273.466M / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 98.702M--
--2024/Q3-- / 81.705M--
Aug 6, 20242024/Q273.466M / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--

Unlock Free Earnings Estimates

TG Therapeutics Earnings Reports

  • TG Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 16:12 ET

  • TG Therapeutics | 10-K/A: Annual report (Amendment)

    Aug 9 16:03 ET

  • TG Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 17:00 ET

  • TG Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 17:29 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data